List of SBIR/STTR awards granted to Naprogenix, Inc.

where

SBIR/STTR Award Recipient

‌

Naprogenix, Inc.

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ NAPROGENIX, INC. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to Naprogenix, Inc. in September, 2021 for $1,016,716.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Naprogenix, Inc.	National Institutes of Health	SBIR	4U44AA026126-03	Phase II	1,016,716	September 1, 2021	sbir.gov/node/2193077
‌ NAPROGENIX, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Naprogenix, Inc. in September, 2018 for $231,474.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Naprogenix, Inc.	National Institutes of Health	SBIR	1R43NS108804-01	Phase I	231,474	September 1, 2018	sbir.gov/node/1568669
‌ NAPROGENIX, INC. SBIR Phase II Award, April 2020	A SBIR Phase II contract was awarded to Naprogenix, Inc. in April, 2020 for $1,030,553.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Naprogenix, Inc.	National Institutes of Health	SBIR	2R44AA025804-03	Phase II	1,030,553	April 5, 2020	sbir.gov/node/1917977
‌ NAPROGENIX, INC. SBIR Phase II Award, September 2020	A SBIR Phase II contract was awarded to Naprogenix, Inc. in September, 2020 for $624,004.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Naprogenix, Inc.	National Institutes of Health	SBIR	2R44NS108804-02	Phase II	624,004	September 30, 2020	sbir.gov/node/1914029
‌ NAPROGENIX, INC. SBIR Phase II Award, September 2013	A SBIR Phase II contract was awarded to Naprogenix, Inc. in September, 2013 for $1,102,755.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	2R44AA018226-03A1	Phase II	1,102,755	September 10, 2013	sbir.gov/node/891373
‌ NAPROGENIX, INC. SBIR Phase I Award, August 2017	A SBIR Phase I contract was awarded to Naprogenix, Inc. in August, 2017 for $1,467,135.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1U44AA026126-01	Phase I	1,467,135	August 25, 2017	sbir.gov/node/1324951
‌ NAPROGENIX, INC. SBIR Phase II Award, April 2017	A SBIR Phase II contract was awarded to Naprogenix, Inc. in April, 2017 for $1,029,017.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	2R44AT008312-02	Phase II	1,029,017	April 1, 2017	sbir.gov/node/1247569
‌ NAPROGENIX, INC. SBIR Phase II Award, September 2016	A SBIR Phase II contract was awarded to Naprogenix, Inc. in September, 2016 for $1,050,389.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R44AA025804-01	Phase II	1,050,389	September 22, 2016	sbir.gov/node/1198141
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $149,697.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	N43AA120010	Phase I	149,697		sbir.gov/node/402229
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $189,844.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R41AT008312-01	Phase I	189,844		sbir.gov/node/706864
‌ NAPROGENIX, INC. STTR Phase II Award,	A STTR Phase II contract was awarded to Naprogenix, Inc. for $183,669.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R42AA016739-01	Phase II	183,669		sbir.gov/node/1070189
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $106,716.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R41CA115093-01A2	Phase I	106,716		sbir.gov/content/novel-estrogen-receptor-ligands-plant-genomics-0
‌ NAPROGENIX, INC. STTR Phase II Award,	A STTR Phase II contract was awarded to Naprogenix, Inc. for $249,230.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	2R42AA014554-02	Phase II	249,230		sbir.gov/content/transgenic-plant-cells-source-hepatoprotective-drugs-0
‌ NAPROGENIX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Naprogenix, Inc. for $285,767.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	275201600001C-0-0-0	Phase II	285,767		sbir.gov/node/1243363
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $272,674.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R43AA018226-01A2	Phase I	272,674		sbir.gov/node/7829
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $97,370.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R41AA014555-01	Phase I	97,370		sbir.gov/node/1066041
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $107,107.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R41AA015475-01	Phase I	107,107		sbir.gov/content/potential-anti-relapse-drugs-plant-genomics-approach-0
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $150,900.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R43AA021038-01	Phase I	150,900		sbir.gov/node/704983
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $106,716.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R41CA115093-01A2	Phase I	106,716		sbir.gov/node/1069869
‌ NAPROGENIX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Naprogenix, Inc. for $107,107.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		SBIR	1R41AA015475-01	Phase I	107,107		sbir.gov/node/1067565
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $97,370.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R41AA014555-01	Phase I	97,370		sbir.gov/content/application-plant-genomics-alcoholic-brain-damage-0
‌ NAPROGENIX, INC. STTR Phase II Award,	A STTR Phase II contract was awarded to Naprogenix, Inc. for $340,250.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	2R42AA015475-02	Phase II	340,250		sbir.gov/content/potential-anti-relapse-drugs-plant-genomics-approach-2
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R41AA014554-01	Phase I	100,000		sbir.gov/content/transgenic-plant-cells-source-hepatoprotective-dr-0
‌ NAPROGENIX, INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Naprogenix, Inc. for $1,128,279.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	1R42AA016739-01	Phase I	1,128,279		sbir.gov/content/hypericum-extracts-potential-anti-relapse-medications-alcoholism-0
‌ NAPROGENIX, INC. STTR Phase II Award,	A STTR Phase II contract was awarded to Naprogenix, Inc. for $699,216.0 USD from the U.S. Department of Health & Human Services.	‌ Naprogenix, Inc.		STTR	9R42AT006639-02A1	Phase II	699,216		sbir.gov/content/novel-estrogen-receptor-ligands-plant-genomics-1

Results per page:

25 results

0 selected

25 results

0 selected